Why we work on Alzheimer’s disease

Translational Medicine by Oxford University

Nov 30, 20166:30Education

Housed within the Target Discovery Institute, the Alzheimer’s Research UK Oxford Drug Discovery Institute (ODDI) juxtaposes drug discovery expertise alongside scientific and academic understanding of patients, disease me...

Related Episodes

Continue listening to more episodes from Translational Medicine.

Molecular diagnosis and bacterial genotyping

Apr 12, 2017 - 4:14

Dr Janjira Thaipadungpanit from our MORU unit in Bangkok, Thailand, tells us about her research on molecu...

Biomarkers for tropical diseases

Apr 12, 2017 - 5:14

Dr Markus Winterbert from our MORU unit in Bangkok, Thailand, tells us about his research on biomarkers f...

MORU Biosafety Level 3 and melioidosis in Thailand

Apr 12, 2017 - 4:01

Premjit Amornchai from our MORU unit in Bangkok, Thailand, tells us about her work as biosafety level 3 l...

Malaria control in Africa

Apr 12, 2017 - 4:47

Professor Bob Snow from our KEMRI-Wellcome programme in Nairobi, Kenya, tells us how his research brings...

Malaria elimination in the Greater Mekong sub-region

Apr 12, 2017 - 5:36

Dr Lorenz von Seidlein from our MORU unit in Bangkok, Thailand, tells us about his research on malaria el...

Tracking infections

Feb 10, 2017 - 6:10

Professor Derrick Crook from our Experimental Medicine division tells us about his research on tracking i...

Mapping bacterial antibiotic resistance

Feb 8, 2017 - 4:46

Dr Olga Tosas-Auguet from our unit in Kenya tells us about her research on mapping bacterial antibiotic r...

Bacterial infections in Laos

Feb 8, 2017 - 6:10

David Dance from our LOMWRU unit in Laos tells us about his research on bacterial infections in Laos, par...